Fund Partners

We were licensed by the Hong Kong Securities and Futures Commission (SFC) to carry on regulated activities of Type 9 (asset management) in December 2012 and Type 4 (advising on securities) in 2016. In 2014, we registered as an Investment Advisor with the U.S. Securities and Exchange Commission (SEC). In the same year, we were recognized as an Asset Manager by the Asset Management Association of China (AMAC).

We were licensed by the Hong Kong Securities and Futures Commission (SFC) to carry on regulated activities of Type 9 (asset management) in December 2012 and Type 4 (advising on securities) in 2016. In 2014, we registered as an Investment Advisor with the U.S. Securities and Exchange Commission (SEC). In the same year, we were recognized as an Asset Manager by the Asset Management Association of China (AMAC).

On the basis of scientific-fundamental analysis, we find the companies in the healthcare sector that promise above-average growth. In particular, the small and medium-sized biotechnology companies stand for innovation and develop the “therapies of tomorrow”.

Gesundheit ist heute eines der wesentlichen Lebensziele überhaupt. Bei der Bewältigung der Herausforderungen können Investorinnen und Investoren mit klugen Entscheidungen einen wichtigen Beitrag leisten. Was ist für Anlegerinnen und Anleger spannend an Healthcare-Investments und was ist dabei zu beachten? Das erfahren Sie im aktuellen Börsen-Espresso der Apo Asset Management GmbH

Blue Box Wealth Management, a Geneva-based multi-family office, partnered with William de Gale, one of Europe’s leading Global Technology Portfolio Managers, to launch the BlueBox Global Technology Fund in March 2018, and so BlueBox Asset Management SA was formed.

Trigon Capital has established itself as a premier partner for investors from around the globe. Over the years Trigon Capital has played a leading role in the Baltics both as a direct investor into leading companies on behalf of international investors and as a more traditional long only equities asset manager. Our well-experienced team of specialists have intimate, on-the-ground knowledge of the Emerging Markets space, and are able to leverage this expertise to provide our clients with a competitive edge.

Slater Investments, an investment management company which provides UK-focused equity products, was set up in 1994 by Mark Slater and Ralph Baber and was initially focused on running segregated mandates for corporate clients and high net worth individuals. This was followed by managing the JF Slater Growth Fund, which was later taken over by Legg Mason. In early 2000, Slater Investments began to manage segregated accounts for defined benefit pension schemes (DB) and defined contribution pension schemes (DC). Slater Investments also manages segregated mandates for Charities, Family Offices and other Institutions.